A Legacy of Clinical Research Excellence Since 2010
Since its inception in 2010, Genelife Clinical Research has been at the forefront of transformative advancements in clinical research in India. Founded with a clear vision — to bring new treatment options to society — we have been at the forefront of innovation, driving progress in clinical trials for the benefit of our clients and, ultimately, patients in need.
Innovative Approaches for Accelerated Clinical Trials
- Fast Patient Recruitment: We pioneered the use of Disease Surveillance Reports to strategize patient recruitment based on therapeutic areas, enabling rapid identification and enrollment of suitable patients.
- High-Quality Data, Low Resource Input: Our working model ensures high-quality data collection with minimal resource requirements — delivering excellence without excessive costs.
- ThemeCore Lab: A unique initiative designed to support clinical trials with core laboratory expertise while keeping expenses in check.
Regulatory Recognition
Throughout our journey, Genelife Clinical Research has stood as a beacon of excellence, meeting stringent standards set forth by renowned regulatory bodies. Our studies have been submitted to and reviewed by esteemed authorities including the US Food and Drug Administration (FDA), Therapeutic Goods Administration (TGA), Federal Institute for Drugs and Medical Devices (BfArM), Drugs Controller General of India (DCGI/CDSCO), and others.
Milestone Achievement: Genelife® Clinical Research is now officially CDSCO-registered as a Clinical Research Organization (CRO) in India — Registration No: CRO/MH/2026/000159.
Awards & Recognition
- Top Healthcare Leaders Global Award — World Health and Wellness Congress & Awards
- Selected among Dynamic Companies in Healthcare during COVID-19
- Healthcare Excellence Award 2020
- Achievers Award (2026)